• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by ASP Isotopes Inc.

    11/7/24 4:15:14 PM ET
    $ASPI
    Major Chemicals
    Industrials
    Get the next $ASPI alert in real time by email
    SC 13G/A 1 p24-3238sc13ga.htm ASP ISOTOPES INC.

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G/A
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*
     

    ASP Isotopes Inc.

    (Name of Issuer)
     

    Common stock, par value $0.01 per share

    (Title of Class of Securities)
     

    00218A105

    (CUSIP Number)
     

    October 31, 2024

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ý Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 6 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 00218A10513G/APage 2 of 6 Pages

     

    1

    NAME OF REPORTING PERSON

    AK Jensen Investment Management Limited

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United Kingdom

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    5

    SOLE VOTING POWER

    5,583,612

    6

    SHARED VOTING POWER

    0

    7

    SOLE DISPOSITIVE POWER

    5,583,612

    8

    SHARED DISPOSITIVE POWER

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    5,583,612

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    8.2%

    12

    TYPE OF REPORTING PERSON

    OO, FI

             

     

     

     

     

    CUSIP No. 00218A10513G/APage 3 of 6 Pages

     

    Item 1(a) NAME OF ISSUER:
       
      The name of the issuer is ASP Isotopes Inc., a Delaware corporation (the “Company”).

     

    Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
       
      The Company's principal executive offices are located at 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.

     

    Item 2(a). NAME OF PERSON FILING:
       
      This statement is filed by AK Jensen Investment Management Limited (“AK Jensen”) with respect to the shares of Common Stock (as defined in Item 2(d) below) held by certain funds and accounts (“AK Jensen Funds”) to which it serves as investment manager.
       
      Anders K. Jensen, a citizen of Norway, and Duncan P. Saville, a citizen of Britain, may be deemed to indirectly control AK Jensen.
       
      AK Jensen is sometimes referred to as the “Reporting Person.”
       
      The filing of this statement should not be construed as an admission that any of the foregoing persons or the Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock reported herein.  

     

    Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
       
      The address of the business office of the Reporting Person is 23 Berkeley Square, Mayfair, London W1J 6HE, United Kingdom.

     

    Item 2(c). CITIZENSHIP:
       
      AK Jensen is a limited company formed under the laws of the United Kingdom.  

     

    Item 2(d). TITLE OF CLASS OF SECURITIES:
       
      Common Stock, par value $0.01 (the “Common Stock”).

     

    Item 2(e). CUSIP NUMBER:
       
      00218A105

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    CUSIP No. 00218A10513G/APage 4 of 6 Pages

     

      (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨

    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); 

      (e) ¨ Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) ¨

    Employee benefit plan or endowment fund in accordance with

    Rule 13d-1(b)(1)(ii)(F);

     

      (g) ¨

    Parent holding company or control person in accordance with

    Rule 13d-1(b)(1)(ii)(G);

     

      (h) ¨

    Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i) ¨

    Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

      (j) ý Non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

     

    If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please

    specify the type of institution: AK Jensen is an investment manager, authorized and regulated by the Financial Conduct Authority in the United Kingdom which is comparable to the regulatory scheme applicable to the investment advisers covered by Item 3(e) above.

     

    Item 4. OWNERSHIP
       
      The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page of the Reporting Person hereto and is incorporated herein by reference.
       
      The percentages set forth herein are calculated based upon 68,409,116 shares of Common Stock outstanding as of September 23, 2024, as reported in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 21, 2024.

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
       
      If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ¨

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
       
      See Item 2(a). the AK Jensen Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock reported herein. Tees River Critical Resources Fund Ltd., an AK Jensen Fund, has the right to receive or the power to direct the receipt of dividends or the proceeds from the sale of more than 5% of the shares of Common Stock.  

     

    CUSIP No. 00218A10513G/APage 5 of 6 Pages

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON.
       
      Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
       
      Not applicable.

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP.
       
      Not applicable.

     

    Item 10. CERTIFICATION.
       
      The Reporting Person hereby makes the following certification:
       
      By signing below the Reporting Person certifies that, to the best of its knowledge and belief, (i) the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect and (ii) the foreign regulatory scheme applicable to AK Jensen is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institutions. The Reporting Person also undertakes to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

     

     

    CUSIP No. 00218A10513G/APage 6 of 6 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATE: November 7, 2024

     

    AK JENSEN INVESTMENT MANAGEMENT LIMITED  
       
       
    By:  /s/ Magnus Benjamin Knudsen  
    Name: Magnus Benjamin Knudsen  
    Title: Head of Fund & Portfolio Analysis  

     

     

     

    Get the next $ASPI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASPI

    DatePrice TargetRatingAnalyst
    10/4/2024$4.50Buy
    Canaccord Genuity
    12/5/2023$3.25Buy
    H.C. Wainwright
    More analyst ratings

    $ASPI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity initiated coverage on ASP Isotopes with a new price target

      Canaccord Genuity initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $4.50

      10/4/24 7:13:36 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • H.C. Wainwright initiated coverage on ASP Isotopes with a new price target

      H.C. Wainwright initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $3.25

      12/5/23 7:36:42 AM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    SEC Filings

    See more
    • ASP Isotopes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - ASP Isotopes Inc. (0001921865) (Filer)

      6/11/25 8:48:50 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • ASP Isotopes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - ASP Isotopes Inc. (0001921865) (Filer)

      6/4/25 10:27:08 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • SEC Form 424B5 filed by ASP Isotopes Inc.

      424B5 - ASP Isotopes Inc. (0001921865) (Filer)

      6/2/25 5:00:26 PM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Ainscow Robert bought 19,992 shares, increasing direct ownership by 2% to 919,992 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/15/24 10:33:49 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • Chief Executive Officer Mann Paul Elliot bought 39,984 shares, increasing direct ownership by 0.69% to 5,845,627 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/15/24 10:33:33 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • Large owner Ak Jensen Investment Management Ltd bought $515,088 worth of shares (161,849 units at $3.18) (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      7/10/24 5:59:47 PM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Ainscow Robert sold $1,121,347 worth of shares (200,000 units at $5.61), decreasing direct ownership by 12% to 1,419,992 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      4/17/25 7:57:41 PM ET
      $ASPI
      Major Chemicals
      Industrials
    • Chief Executive Officer Mann Paul Elliot sold $5,326,397 worth of shares (950,000 units at $5.61), decreasing direct ownership by 11% to 7,315,454 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      4/17/25 7:57:18 PM ET
      $ASPI
      Major Chemicals
      Industrials
    • Chief Operating Officer Ainscow Robert was granted 400,000 shares, increasing direct ownership by 33% to 1,619,992 units (SEC Form 4)

      4 - ASP Isotopes Inc. (0001921865) (Issuer)

      4/15/25 8:42:42 AM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Renergen's Phase 2 EPC Contractor Awarded Preferred Bidder Status

      JOHANNESBURG, June 18, 2025 (GLOBE NEWSWIRE) -- Renergen is pleased to announce that preferred bidder status has been awarded to He4u consortium for the design, procurement, delivery, construction and commissioning for phase 2 of the Tetra4 LNG and helium liquefaction project, comprising of, Chart Industries Inc. (NYSE:GTLS), Wilson Bayly Holmes - Ovcon Ltd (JSE: WBO), and Aurex Constructors. The appointment of an acceptable EPC contractor in Phase 2 was one of the two remaining conditions for the DFC Phase 2 loan. The award is a key milestone in the project's progress. The award confirms that Chart Industries' Helium liquefier and LNG liquefaction technologies have been selected as Tet

      6/18/25 10:11:04 AM ET
      $ASPI
      $GTLS
      Major Chemicals
      Industrials
      Metal Fabrications
    • Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream

      MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 83rd Emerging Growth Conference on June 17 & 18, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 – Presenting today, June 17, 2025 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go

      6/17/25 7:00:00 AM ET
      $AEMD
      $ASPI
      $COE
      $JAGX
      Medical/Dental Instruments
      Health Care
      Major Chemicals
      Industrials
    • Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream

      MIAMI, June 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 83rd Emerging Growth Conference on June 17 & 18, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1June 17, 2025 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go back to the regist

      6/16/25 7:00:00 AM ET
      $AEMD
      $ASPI
      $COE
      $JAGX
      Medical/Dental Instruments
      Health Care
      Major Chemicals
      Industrials

    $ASPI
    Leadership Updates

    Live Leadership Updates

    See more
    • Renergen's Phase 2 EPC Contractor Awarded Preferred Bidder Status

      JOHANNESBURG, June 18, 2025 (GLOBE NEWSWIRE) -- Renergen is pleased to announce that preferred bidder status has been awarded to He4u consortium for the design, procurement, delivery, construction and commissioning for phase 2 of the Tetra4 LNG and helium liquefaction project, comprising of, Chart Industries Inc. (NYSE:GTLS), Wilson Bayly Holmes - Ovcon Ltd (JSE: WBO), and Aurex Constructors. The appointment of an acceptable EPC contractor in Phase 2 was one of the two remaining conditions for the DFC Phase 2 loan. The award is a key milestone in the project's progress. The award confirms that Chart Industries' Helium liquefier and LNG liquefaction technologies have been selected as Tet

      6/18/25 10:11:04 AM ET
      $ASPI
      $GTLS
      Major Chemicals
      Industrials
      Metal Fabrications
    • ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC (QLE) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE

      WASHINGTON , June 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Dr. Ryno Pretorius, PhD as Chief Executive Officer of Quantum Leap Energy LLC (QLE), the Company's subsidiary that is pursuing an initiative to develop and commercialize advanced nuclear fuels, such as High Assay Low-Enriched Uranium (HALEU) and Lithium-6. Dr. Pretorius has previously served as a consultant to both ASP Isotopes and QLE. Paul Mann will continue to serve as the chairman and C

      6/11/25 8:23:05 AM ET
      $ASPI
      Major Chemicals
      Industrials
    • ASP Isotopes Inc. Enhances Executive Leadership Team with the Appointment of Heather Kiessling as Chief Financial Officer

      WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Heather Kiessling as its chief financial officer (CFO), effective as of July 1, 2024 (or such earlier date as may be mutually agreed), to support the Company's next pivotal phase of growth. Robert Ainscow, who currently serves as the Company's CFO and chief operating officer (COO), will continue to serve as the Company's COO, enabling him to focus his full time and attention on the Company's operat

      6/13/24 10:56:52 AM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Financials

    Live finance-specific insights

    See more
    • Mobilicom and ASP Isotopes Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / September 13, 2024 / RedChip Companies will air interviews with Mobilicom Ltd. (NASDAQ:MOB) and ASP Isotopes Inc. (NASDAQ:ASPI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 14, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Mobilicom: https://www.redchip.com/assets/access/mob_accessASP Isotopes: https://www.redchip.com/assets/access/aspi_accessOren Elkayam, Founder and CEO of Mobilicom, appears on the RedChip Small Stocks, Big Money™ show on Bloomberg TV to provide a corporate update. Mobilicom presents a

      9/13/24 9:00:00 AM ET
      $ASPI
      $BOXL
      $MOB
      Major Chemicals
      Industrials
      Other Consumer Services
      Real Estate
    • ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / May 24, 2024 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and Calidi Biotherapeutics Inc. (NYSE:CLDI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, May 25, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:ASP Isotopes: https://www.redchip.com/assets/access/aspi_accessCalidi Biotherapeutics: https://www.redchip.com/assets/access/cldi_accessIn an exclusive interview, Paul Mann, CEO of ASP Isotopes, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate u

      5/24/24 9:00:00 AM ET
      $ASPI
      $CLDI
      Major Chemicals
      Industrials
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

      ORLANDO, FL / ACCESSWIRE / January 19, 2024 / RedChip Companies will air interviews with INNO Holdings, Inc. (NASDAQ:INHD) and ASP Isotopes, Inc. (NASDAQ:ASPI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, January 20, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:INNO Holdings: https://www.redchip.com/assets/access/inhd_accessASP Isotopes: https://www.redchip.com/assets/access/aspi_accessIn an exclusive interview, Alice Gong, COO of INNO Holdings, appears on the RedChip Small Stocks Big Money® Show on Bloomberg TV to provide a corporate update

      1/19/24 1:10:00 PM ET
      $ASPI
      Major Chemicals
      Industrials

    $ASPI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by ASP Isotopes Inc.

      SC 13G - ASP Isotopes Inc. (0001921865) (Subject)

      11/14/24 3:01:19 PM ET
      $ASPI
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by ASP Isotopes Inc.

      SC 13G/A - ASP Isotopes Inc. (0001921865) (Subject)

      11/7/24 4:15:14 PM ET
      $ASPI
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by ASP Isotopes Inc.

      SC 13G - ASP Isotopes Inc. (0001921865) (Subject)

      11/3/23 4:15:20 PM ET
      $ASPI
      Major Chemicals
      Industrials